Eight participants were reported to produce antibodies to COVID-19, in a vaccine trial by Moderna Inc. The findings are 'significant' but further tests still need to be taken. If the vaccine is successful, the pharmaceutical company is hoping to supply millions of doses per month in 2020 and, with further investments, tens of millions a month in 2021.WorldEconomicForum
Tuesday, May 19, 2020
Coronavirus: Here’s everything you need to know about the Moderna vaccine
Eight participants were reported to produce antibodies to COVID-19, in a vaccine trial by Moderna Inc. The findings are 'significant' but further tests still need to be taken. If the vaccine is successful, the pharmaceutical company is hoping to supply millions of doses per month in 2020 and, with further investments, tens of millions a month in 2021.WorldEconomicForum
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment